Tesla (NASDAQ:TSLA) came out of its Q4 2024 earnings call in bright spirits, despite weakening EV delivery and sales numbers.
An announcement from Dr Reddy’s Laboratories ( ($RDY) ) is now available. On February 4, 2025, Dr. Reddy’s Laboratories announced its ...
Dr Reddy’s Laboratories ( ($RDY) ) has shared an update. On February 4, 2025, Dr. Reddy’s Laboratories announced its participation in an investor ...
Maxim lowered the firm’s price target on Flux Power (FLUX) to $4 from $6 and keeps a Buy rating on the shares. The firm cites ...
Steakholder Foods (STKH) shared a letter from its CEO Arik Kaufman, which read in part, “As we enter 2025, our primary ...
The TipRanks All-star Analyst of the Day title goes to Analyst Mariana Perez Mora of research firm Bank of America Securities ...